Search

Your search keyword '"Diallo, Fatoumata"' showing total 219 results

Search Constraints

Start Over You searched for: Author "Diallo, Fatoumata" Remove constraint Author: "Diallo, Fatoumata" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
219 results on '"Diallo, Fatoumata"'

Search Results

1. rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)

2. Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

6. Vaccination strategies for Ebola in the democratic republic of Congo: the who-Ebola modeling collaboration

7. Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5.

9. Safety and immunogenicity of a single dose of Tdap compared to Td in pregnant women in Mali and 3 its effect on infant immune responses: a single-centre, randomised, double-blind, active-controlled phase 2 study

10. Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali

11. Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial

17. Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein

20. Strategies to attract and retain infection prevention and control nurses in the era of nursing shortage.

21. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials

30. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial

33. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

36. Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age

37. Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years

38. Disruption of Healthcare in New York City During the COVID-19 Pandemic: Findings From Residents Living in North and Central Brooklyn, the South Bronx, and East and Central Harlem.

39. CAUSES DE DÉCÈS AU SERVICE DE MÉDECINE DE L'HÔPITAL RÉGIONAL DE SIKASSO.

40. PREPARING A CLASS IN THE CONTEXT OF COMPUTER ASSISTED LANGUAGE LEARNING: ADDRESSING THE CRITICAL ASPECT OF SYLLABUS DESIGN.

41. Efficacy of the oral pentavalent rotavirus vaccine in Mali

42. Participation des parents a un programme d'education nutritionnel implante en milieu scolaire et developpement de comportements alimentaires des enfants

43. Resistance profile of bacteria isolated from the environment of high-risk departments in Ziguinchor hospitals.

44. Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children.

45. Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children.

46. A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement.

47. Comparison of Thromboelastography Devices TEG® 6S Point of Care Device vs. TEG® 5000 in Pediatric Patients Undergoing Cardiac Surgery.

48. Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

49. Morbidities and mortality of diagnosed attention deficit hyperactivity disorder (ADHD) over the youth lifespan: A population‐based retrospective cohort study.

50. Comparison of Thromboelastography Devices TEGVR 6S Point of Care Device vs. TEGVR 5000 in Pediatric Patients Undergoing Cardiac Surgery.

Catalog

Books, media, physical & digital resources